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Figure 3
C-28/I2 and SW982, and reduced MMP-13 expression in C-28/I2 (Fig. 2).
Promoter assay was showed that C/EBPβ stimulates the promoter activities
of MMP-3 and -13 in a dose-dependent manner (Fig. 3). Deletion analysis
revealed the C/EBPβ responsive elements in the promoter of MMP-3 and
-13. ChIP assay was performed using primers constructed from the human
MMP-3, -13 and ADAMTS-5 promoter sequences which amplify the sites
included the C/EBPβ consensus binding motifs. This analysis indicated that
C/EBPβ binds to these promoter regions.
Conclusions: C/EBPβ mediates multiple factors in arthritis. For example,
C/EBPβ activates factors of inﬂammation, such as phospholipase A2 and
cyclooxygenase-2. C/EBPβ also mediates the repression of cartilage derived-
retinoic acid sensitive protein (CD-RAP) in response to IL-1β. It is also
reported that C/EBPβ mediates the expression of MMP-1. Furthermore, it
is reported that C/EBPβ mediates signals for the hypertrophic change of
chondrocyte in OA cartilage. In this study we showed that C/EBPβ is also
involved in the expression of MMP-3, 13 and ADAMTS-5 in synovium and
cartilage of arthritis. These results suggest that C/EBPβ plays important
roles in the catabolic processes in arthritis cartilage.
202
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Purpose: In cartilage regenerative techniques, inferior collagen content
of cartilage constructs is a major complicating factor. COX-2 is essential
during fracture healing as knockout of COX-2 impairs fracture healing.
Furthermore, mesenchymal progenitor cells and the developing growth
plate show COX-1 and COX-2 expression, indicating a role for COX- en-
zymes during endochondral ossiﬁcation. However, it is poorly understood
how COX-1 and COX-2 are regulated during chondrogenesis and by which
molecular mechanisms they inﬂuence chondrogenic differentiation and
collagen synthesis. We hypothesize that chondrogenesis can be modulated
by manipulation of COX activity.
Methods: The chondrogenic progenitor cell line ATDC5 and dedifferenti-
ated primary human articular chondrocytes (HACs) were (re)differentiated.
COX-activity was inhibited by increasing concentrations of COX-1 and COX-
2 non-speciﬁc and speciﬁc inhibitors (NSAIDs: indomethacin, mofezolac
and NS398, respectively) added from different time points in differentia-
tion. Protein and mRNA expression of Col2A1, Col10A1 and COX-1/2 was
analyzed at day 14 (ATDC5) or day 7 (primary chondrocytes) in cell lysates
by RT-qPCR and immunoblot analysis.
Results: Addition of the non-speciﬁc NSAID indomethacin from the start
of ATDC5 differentiation heavily affected Col2A1 and Col10A1 expression.
In contrast, redifferentiation of primary human chondrocytes was not
affected when a similar indomethacin concentration (20 μM) was used.
Surprisingly, Col2A1 and Col10A1 synthesis was enhanced in the latter
cultures. This seemingly paradoxal effect might be explained by differential
roles of COX-1 and COX-2 during different chondrogenic phases. Indeed,
addition of indomethacin during ATDC5 differentiation from day 8 (when
ATDC5 adopts chondrocyte characteristics) resulted in a similar increased
Col2A1 and Col10A1 expression as in redifferentiation of primary HACs
with indomethacin. To elucidate the role of the individual COX-enzymes
during different chondrogenic phases, speciﬁc COX-1 and COX-2 inhibitors
were added to ATDC5 cells from the start or from day 8 in differentiation.
When added from day 0, mofezolac (COX-1 speciﬁc) dose-dependently
decreased Col10A1 synthesis similar to indomethacin, but increased Col2A1
synthesis. When added from day 8, mofezolac showed an overall decreased
collagen synthesis. In contrast, NS398 (COX-2 speciﬁc) speciﬁcally inhibited
Col10A1 and did not inﬂuence Col2A1 expression when added from the
start of ATDC5 differentiation. Addition of NS398 from day 8 in ATDC5
differentiation resulted in increased Col2A1 expression and only slightly
increased Col10A1 expression.
Conclusions: Our ﬁndings point to a differential and differentiation phase
dependent role for COX-enzymes during chondrogenesis. Our preliminary
data show that the expression levels of COX-1 and COX-2 depend on the
chondrocyte differentiation phase, thereby partly explaining differential
effects of NSAIDs during different chondrogenic phases. Ongoing research
focuses on further elucidating the functional partition of COX-enzymes
and prostaglandins during chondrogenesis for improving the outcome of
cartilage regenerative techniques.
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Purpose: Articular chondrocytes are not known to migrate in vivo, yet
they express chemokine receptors. The function of ELR+ CXC chemokine
receptors in these cells is therefore unknown. In addition to the receptors,
chondrocytes also express their ligands thereby suggesting a paracrine-
autocrine signalling mechanism. In this study we have hypothesised that
ELR+ CXC chemokine signalling via the receptors CXCR1 and CXCR2
in chondrocytes has a physiological role in cartilage homeostasis and
particularly in the maintenance of the chondrocytic phenotype.
Methods: Adult human articular chondrocytes (AHAC) were isolated by
enzymatic release from preserved areas of the femoral condyles of patients
undergoing joint replacement for osteoarthritis. Chondrocytes were ex-
panded in monolayer culture under standard conditions. Gene expression
analysis was performed by real time quantitative PCR and at protein level,
the expression of CXCR1 and CXCR2 was conﬁrmed using Western blot and
immunoﬂuorescence. CXCR-1/-2 functionality was tested using a calcium
inﬂux assay. CXCR-1/-2 signalling was either blocked at the Gαi level using
pertussis toxin or at the receptor level using blocking antibodies. The
expression of molecular markers associated with the stable cartilage phe-
notype was assessed using real time PCR. The content of highly sulphated
proteoglycans in chondrocyte micromasses was analysed using Alcian blue
staining at pH0.2 followed by guanidine extraction and spectrophotometric
quantiﬁcation.
Results: Early passage articular chondrocytes expressed CXCL1, CXCL8 and
CXCL6 as well as their receptors CXCR1 and CXCR2. CXCR1 and CXCR2 ex-
pression was conﬁrmed at protein level by Western blotting, and receptor
functionality was shown by an increase in calcium inﬂux following ligand
stimulation. Confocal microscopy conﬁrmed the localisation of both recep-
tors at the cell membrane as well as within the cytoplasm, as expected for
the well known internalisation and recycling of these receptors and for the
autocrine/paracrine production of their ligands. The expression of both the
ligands and receptors was conﬁrmed at mRNA and protein level in freshly
dissected cartilage biopsies. Blocking CXCR1/2 signalling at both G protein
and at receptor level in early passage AHAC resulted in a downregulation
of type II collagen, aggrecan and SOX9 mRNA. In addition, CXCR blockade
in chondrocyte micromasses resulted in a net decrease of highly sulphated
glycosaminoglycan content as evaluated by Alcian blue staining. However,
supplementation of CXCR1 and CXCR2 ligands during cell expansion did
not lead to an enhanced cartilage phenotype or to the maintenance of
phenotypic molecular markers at gene expression level.
Conclusions: CXCR1 and CXCR2 are expressed and are functional in adult
human cartilage and cultured articular chondrocytes.
CXCR1 and CXCR2 blockade results in the downregulation of some but not
all molecular markers associated with the capacity of AHAC to form stable
cartilage in vivo.
CXCR signalling is required for the phenotypic stability of articular chon-
drocytes in vitro and therefore may play a role in cartilage homeostasis in
vivo.
CXCR1 and CXCR2 supplementation is not suﬃcient to maintain the
phenotypic stability of articular chondrocytes during in vitro expansion.
